Eyepoint Pharmaceuticals Shares Spike to Premarket Highs; Co on Saturday Announced Wet AMD Trial Results Showed 76% and 53% of Patients Were Rescue-free Up to Four & Six Months, Respectively, After Single Injection of EYP-1901